People with type 2 diabetes Retatrutide has been studied specifically in people with type 2 diabetes, and the results are positive
To put that in perspective, semaglutide achieved approximately 15% and tirzepatide approximately 21% in their respective trials
J Bone Miner Res 33:975986 Shanbhogue VV, Stving RK, Frederiksen KH et al (2017) Bone structural changes after gastric bypass surgery evaluated by HR-pQCT: a two-year longitudinal study
Contraindications Do Not Use If You Have a personal or family history of medullary thyroid carcinoma (MTC) Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Have had a serious hypersensitivity reaction to semaglutide or any component of the formulation Are pregnant, planning to become pregnant, or breastfeeding Warnings and Precautions Pancreatitis: Acute and chronic pancreatitis have been reported
According to the October 2024 multi-society guidance from the American Society of Anesthesiologists (ASA), American Gastroenterological Association (AGA), American College of Gastroenterology (ACG), American Society for Gastrointestinal Endoscopy (ASGE), and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), most patients can safely continue their GLP-1 medications before elective procedures with appropriate risk mitigation strategies
Physiol Rev 87, 1409-1439
